We also observed that YAP2 expression inhibits ovarian cancer cell death induced by cisplatin treatment and the inhibition of PP1A with okadiac acid increases the phosphorylation and cytoplasmic translocation as well as the drug resistance capability of YAP2. Here, YAP1 is linked to ovarian carcinoma.